It is also the psychiatric illness that holds the record for having the highest mortality rate. The UCSD research explores ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Revive Therapeutics (TSE:RVV) has released an update. Revive Therapeutics has announced promising research showcasing psilocybin’s ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...

However, not everyone with depression will be eligible for this innovative treatment. The study, led by researchers from ...

'Functional unblinding was a major barrier to the approval of psychedelics as medicines to treat the patients who need them most,' said Dr. Andrew Chadeayne, CaaMTech CEO. 'I'm incredibly proud that ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced ...

A former firefighter tried psilocybin in his backyard, and got amazing relief. Slowly, medical research is starting to ...

Our commitment to pioneering novel oral synthetic cannabinoid combination therapeutics and our oral synthetic psilocybin treatment remains strong, and we look forward to sharing further updates in the ...

If the Colorado Springs City Council approves the zoning measure, it would essentially bar the centers from operating in ...